Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes.
about
The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 DiabetesAmpelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling PathwayAlantolactone Improves Prolonged Exposure of Interleukin-6-Induced Skeletal Muscle Inflammation Associated Glucose Intolerance and Insulin Resistance.Protein tyrosine phosphatase-1B modulates pancreatic β-cell massKnockout of STAT3 in skeletal muscle does not prevent high-fat diet-induced insulin resistance.High Glucose Induces Down-Regulated GRIM-19 Expression to Activate STAT3 Signaling and Promote Cell Proliferation in Cell CultureTyrosine 705 Phosphorylation of STAT3 Is Associated with Phenotype Severity in TGFβ1 Transgenic Mice.Activation of G proteins by GIV-GEF is a pivot point for insulin resistance and sensitivity.Signal transducer and activator of transcription 3 signaling as a potential target to treat muscle wasting diseases.Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to benchContrasting metabolic effects of medium- versus long-chain fatty acids in skeletal muscle.Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetesSystem Level Meta-analysis of Microarray Datasets for Elucidation of Diabetes Mellitus Pathobiology.Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise.The JAK/STAT pathway in obesity and diabetes.Electrical pulse stimulation of cultured skeletal muscle cells as a model for in vitro exercise - possibilities and limitations.Methylation and microRNA-mediated epigenetic regulation of SOCS3.Effect of Exercise Training on Signaling of Interleukin-6 in Skeletal Muscles of Type 2 Diabetic Rats.Molecular mechanisms of insulin resistance in chronic kidney disease.Role of the JAK2/STAT3 signaling pathway in the pathogenesis of type 2 diabetes mellitus with macrovascular complications.Plasma interleukin-22 levels are associated with prediabetes and type 2 diabetes in the Han Chinese population.Skeletal muscle inflammation and insulin resistance in obesity.Aortic carboxypeptidase-like protein, a WNT ligand, exacerbates nonalcoholic steatohepatitis.The Yin and Yang of Tyrosine Kinase Inhibition During Experimental Polymicrobial Sepsis.Icariin Ameliorates Palmitate-Induced Insulin Resistance Through Reducing Thioredoxin-Interacting Protein (TXNIP) and Suppressing ER Stress in C2C12 Myotubes
P2860
Q28546913-12CC79B0-4588-482F-8C17-41C817AA22E8Q28552475-84F2E646-167A-4850-9986-6F4C0CD153CEQ33849609-32596C48-2585-4606-9D7E-21C797D09C76Q35108980-894CBD16-392B-4B9F-AE7D-015B2EA6C361Q35929484-F0BA9453-2E2B-45D7-8BD8-EC573A84FA2BQ35996269-BFDF07DA-AB87-47EC-A5A1-A2CAF726451CQ36031911-E7C4F840-30BA-41AF-866F-2FB3BB7302CDQ36274510-2AA7478B-1AE8-4EF0-9834-EEB32CCDE976Q36900212-ED53DE1B-9BB8-446F-B032-82B31FB259FCQ37171547-76A0AAFA-CB00-4084-8F3C-25CA6B981AC3Q37305373-92710849-FB54-48CA-B24E-DB6172FCEF09Q37490734-F8F99DF6-E6DB-4F71-95AB-E00EC9BCCA5EQ38703657-CE5B60A6-117F-4437-9794-38C009FC7E63Q38727298-16FF1D0E-C57F-47C1-9ED2-E88B81B27AFBQ38773189-97C366D9-F39E-408E-917A-792062018105Q39013187-92069B2D-08BE-4764-B648-4C066A2EC14DQ41240274-EECD1D7D-D524-4629-AFA6-999532862DB0Q41363191-3496F74E-886E-4091-B7AF-EA9E4BAD7080Q43135175-7078DD61-9361-4C30-9A4E-B9D15A536B66Q47120820-B88DFECB-8C00-4373-AC4A-480F606BFABEQ49246280-3ABDF73B-A9B5-429B-B290-CBCAE622C397Q50308557-3F47B5F5-5F33-467E-9DBD-A99A85C03DB7Q52350739-264FA13F-A26A-4B59-913E-67EACAC04D01Q54109924-B8CD4482-BDEF-4411-AA40-98B625504B05Q59127969-3FD610A9-7BE8-4B35-86B0-8D6A35E2E7EF
P2860
Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Constitutive STAT3 phosphoryla ...... resistance in type 2 diabetes.
@ast
Constitutive STAT3 phosphoryla ...... resistance in type 2 diabetes.
@en
type
label
Constitutive STAT3 phosphoryla ...... resistance in type 2 diabetes.
@ast
Constitutive STAT3 phosphoryla ...... resistance in type 2 diabetes.
@en
prefLabel
Constitutive STAT3 phosphoryla ...... resistance in type 2 diabetes.
@ast
Constitutive STAT3 phosphoryla ...... resistance in type 2 diabetes.
@en
P2860
P50
P921
P356
P1433
P1476
Constitutive STAT3 phosphoryla ...... resistance in type 2 diabetes.
@en
P2093
Fredirick Mashili
P2860
P304
P356
10.2337/DB12-0337
P407
P577
2012-10-05T00:00:00Z